Comments
Loading...

Amplify Weight Loss Drug & Treatment ETF Holdings

THNRARCA
Logo brought to you by Benzinga Data
$25.47
0.190.76%
Last update: Dec 15, 9:58 AM

As of Nov 28, 2025

Number of Stock Holdings
19
Number of Bond Holdings
-
Total Holdings
21
Number of ETFs
-

Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR), Top Holdings

Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR)

TickerNameShare %
LLYEli Lilly & Co.16.07%
CONovo Nordisk A/S ADR10.28%
LNDeveloped Markets Astrazeneca Plc Sponsored Adr5.17%
AMGNAmgen Inc.7.38%
PFEPfizer, Inc.4.69%
JPChugai Pharmaceutical Co. Ltd. Com Stk7.14%
SMRoche Holding Ag5.13%
MRKMerck & Co. Inc.5.57%
REGNRegeneron Pharmaceuticals, Inc.8.27%
ABBVAbbvie Inc.4.68%

FAQ

Q

How has THNR ETF performed?

A

The THNR ETF is currently trading at $25.47, which represents a 0.76% change. Over the past 52 weeks, the ETF has traded as high as $26.27 and as low as $18.56.

Q

What is the expense ratio for THNR?

A

The expense ratio of THNR is 0.59%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for THNR?

A

The total Assets Under Management (AUM) for THNR is 2.78M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for THNR?

A

THNR follows a Large Cap Blend investment style.

Q

What are the top holdings for THNR?

A

The top holdings of THNR include: LLY (16.07%), CO (10.28%), LN (5.17%), AMGN (7.38%), PFE (4.69%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for THNR?

A

Average daily volume data for THNR is currently not available.